Plant Advanced Technologies PAT EBIT per Share
The EBIT per Share of Plant Advanced Technologies PAT (ALPAT.PA) as of Aug 16, 2026 is 0.19 EUR. In the previous year, EBIT per Share was -0.71 EUR — a change of -126.78% (higher).
Get this data via API
Financial Data API
EBIT per Share
0.19EUR
YoY
-126.78%
Last updated:
EBIT per Share of Plant Advanced Technologies PAT is 2026 0.19 EUR. EBIT per Share of Plant Advanced Technologies PAT was 2025 -0.71 EUR. It decreases by -126.78% higher compared to the previous year.
Access this data via the Eulerpool API
Plant Advanced Technologies PAT Stock analysis
What does Plant Advanced Technologies PAT do? Plant Advanced Technologies, or PAT SA, is an innovative company that was founded in 2002. The company is based in France, specifically in Larchamp, where it operates a pilot plant for the production of plant extracts. PAT SA is a leading developer and manufacturer of sustainable plant-based ingredients for the cosmetic, food, pharmaceutical, and nutraceutical industries.
Business model
PAT SA's business model is based on the development, production, and marketing of innovative plant-based ingredients using biotechnological processes and plant cell culture. Through this method, they are able to produce unlimited plant-based ingredients of the highest quality and purity. PAT SA also works closely with its customers in each industry to develop customized solutions for their specific needs.
Divisions
PAT SA is divided into three divisions or business areas to enhance its performance and flexibility:
1. Cosmetics
PAT SA's cosmetics division offers a wide range of plant-based ingredients for various applications in skincare, hair care, and decorative cosmetics. PAT SA aims to produce cosmetics that are not only safe and effective, but also sustainable and based on natural ingredients.
2. Food and Nutraceuticals
PAT SA's food and nutraceutical division focuses on the development of plant-based ingredients for food as well as dietary supplements and functional foods. PAT SA's offerings include antioxidants, anti-aging ingredients, immune stimulators, and many more.
3. Pharmaceuticals
PAT SA's pharmaceutical division specializes in the development and production of plant-based ingredients for the pharmaceutical industry. PAT SA focuses on producing ingredients for the therapy of certain diseases such as cancer, diabetes, and inflammatory diseases.
Products
PAT SA offers a wide range of plant-based ingredients targeting different needs:
1. Alpha Heptyl Glucoside (AHG)
AHG is an innovative plant-based ingredient that is used in many cosmetic applications. The ingredient has a restorative effect on the skin and hair, improving their appearance, firmness, and elasticity.
2. Snovita
Snovita is a patented extract from the snow aster plant. The ingredient acts on the melanocytes responsible for skin pigmentation. Snovita stimulates cell regeneration and provides an effective solution for anti-aging and brightening products.
3. Rosadextrin
Rosadextrin is a high-quality extract from red algae suitable for skincare applications. The ingredient is rich in antioxidants and has anti-inflammatory properties, strengthening the skin barrier and reducing the visibility of wrinkles and fine lines.
Conclusion
Overall, PAT SA is an innovative company specializing in the development and production of plant-based ingredients for the cosmetic, food, pharmaceutical, and nutraceutical industries. By utilizing biotechnological processes and plant cell cultures, PAT SA offers its customers high-quality, sustainable, and high-performance solutions based on natural ingredients. With its three divisions and extensive product offering, PAT SA demonstrates its versatility and ability to adapt to different application areas. Plant Advanced Technologies PAT is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Plant Advanced Technologies PAT stock
EBIT per Share of Plant Advanced Technologies PAT is 0.19 EUR in 2026.
EBIT per Share of Plant Advanced Technologies PAT changed from -0.71 EUR to 0.19 EUR, representing a -126.78% change. The value is higher than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Plant Advanced Technologies PAT since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Plant Advanced Technologies PAT
All Key Metrics — Plant Advanced Technologies PAT
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth